Page last updated: 2024-10-25

clobenpropit and Spinal Cord Injuries

clobenpropit has been researched along with Spinal Cord Injuries in 1 studies

clobenpropit: histamine H3 receptor antagonist
clobenpropit : An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM.

Spinal Cord Injuries: Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Buzoianu, AD1
Sharma, A1
Muresanu, DF1
Feng, L1
Huang, H1
Chen, L1
Tian, ZR1
Nozari, A1
Lafuente, JV1
Sjöqvist, PO1
Wiklund, L1
Sharma, HS1

Other Studies

1 other study available for clobenpropit and Spinal Cord Injuries

ArticleYear
Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury.
    International review of neurobiology, 2023, Volume: 172

    Topics: Antioxidants; Drug Inverse Agonism; Histamine Agonists; Humans; Nanowires; Neuroprotection; Quality

2023